| RS2074119405 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 1, Diamond-Blackfan anemia 1 |
| RS2074126696 |
RPS19
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2074126900 |
RPS19
|
Health Risk |
Pathogenic |
— |
| RS2074170793 |
TMC6
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS2074173475 |
PIGW
|
Health Risk |
Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 5, Hyperphosphatasia with intellectual disability syndrome 5 |
| RS2074181394 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2074186150 |
MYH3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2074191627 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS2074248065 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS2074254630 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2074256645 |
MYH3
|
Health Risk |
Likely pathogenic |
Distal arthrogryposis, Distal arthrogryposis |
| RS2074277177 |
WRAP53
|
Health Risk |
Likely pathogenic |
— |
| RS2074282243 |
MYH3
|
Health Risk |
Likely pathogenic |
— |
| RS2074282420 |
SNHG14;UBE3A
|
Health Risk |
Likely pathogenic |
— |
| RS2074288628 |
UBE3A
|
Health Risk |
Likely pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2074302214 |
UBE3A
|
Health Risk |
Pathogenic |
— |
| RS2074311354 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS2074317360 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2074317922 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS2074335019 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS2074335877 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS2074344245 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS2074353310 |
MCM2
|
Health Risk |
Likely pathogenic |
— |
| RS2074357706 |
GP6
|
Health Risk |
Pathogenic |
— |
| RS2074369642 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2074372905 |
IQSEC2
|
Health Risk |
Pathogenic |
— |
| RS2074373583 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2074374579 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2074379209 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2074381038 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2074381441 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Facioscapulohumeral muscular dystrophy 2 |
| RS2074383129 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2074383291 |
IQSEC2
|
Health Risk |
Pathogenic |
— |
| RS2074385548 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2074387117 |
KCNJ2
|
Health Risk |
Pathogenic |
Andersen Tawil syndrome, Short QT syndrome type 3 |
| RS2074388917 |
KCNJ2
|
Health Risk |
Pathogenic |
Andersen Tawil syndrome, Short QT syndrome type 3 |
| RS2074390325 |
KCNJ2
|
Health Risk |
Likely pathogenic |
Andersen Tawil syndrome, Short QT syndrome type 3 |
| RS2074401700 |
GTPBP3
|
Health Risk |
Pathogenic |
— |
| RS2074414994 |
TMC6
|
Health Risk |
Likely pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS2074426876 |
GTPBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2074437028 |
IQSEC2
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS2074441517 |
SLC24A1
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy, Moyamoya angiopathy |
| RS2074443699 |
SLC24A1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2074443766 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2074450400 |
SLC24A1
|
Health Risk |
Pathogenic |
— |
| RS2074458024 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS2074488502 |
PLP1;RAB9B
|
Health Risk |
Likely pathogenic |
Spasticity, Spasticity |
| RS2074490307 |
PLP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS2074492359 |
UBE3A
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2074497991 |
PLP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 2, Pelizaeus-Merzbacher disease |
| RS2074498206 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS2074504404 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2074506871 |
PLP1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 2, Pelizaeus-Merzbacher disease |
| RS2074508602 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2074510916 |
PLP1;RAB9B
|
Health Risk |
Likely pathogenic |
— |
| RS2074511604 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2074517785 |
PLP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS2074519196 |
SDCCAG8
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 7, Bardet-Biedl syndrome 16 |
| RS2074521998 |
CNOT3
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2074547544 |
CNOT3
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2074549354 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2074555124 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2074565202 |
CASR
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant hypocalcemia 1, Nephrolithiasis/nephrocalcinosis |
| RS2074565392 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS207459999 |
MT-CYB
|
Health Risk |
Likely pathogenic |
Mitochondrial encephalomyopathy, Leigh syndrome |
| RS207460000 |
MT-CYB
|
Health Risk |
Likely pathogenic |
Exercise intolerance, Mitochondrial myopathy with reversible cytochrome C oxidase deficiency |
| RS207460005 |
MT-CYB
|
Health Risk |
Likely pathogenic |
Parkinsonism/MELAS overlap syndrome, Mitochondrial disease |
| RS2074624616 |
CASR
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2074631977 |
CASR
|
Health Risk |
Pathogenic |
Nephrolithiasis/nephrocalcinosis, Nephrolithiasis/nephrocalcinosis |
| RS2074634164 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2074638284 |
CNOT3
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy with developmental delay, Moyamoya angiopathy with developmental delay |
| RS2074639464 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS207465619 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2074663472 |
PLS3
|
Health Risk |
Likely pathogenic |
— |
| RS2074664927 |
PLS3
|
Health Risk |
Pathogenic |
Bone mineral density quantitative trait locus 18, Bone mineral density quantitative trait locus 18 |
| RS2074682724 |
IDH3A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 90, Retinitis pigmentosa 90 |
| RS2074683444 |
IDH3A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 90, Retinitis pigmentosa 90 |
| RS2074694091 |
DYM
|
Health Risk |
Pathogenic |
Dyggve-Melchior-Clausen syndrome, Dyggve-Melchior-Clausen syndrome |
| RS2074694480 |
TMPRSS15
|
Health Risk |
Pathogenic |
— |
| RS2074705330 |
IDH3A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 90, Retinitis pigmentosa 90 |
| RS2074707744 |
IDH3A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 90, Retinitis pigmentosa 90 |
| RS2074708654 |
IDH3A
|
Health Risk |
Likely pathogenic |
— |
| RS2074729420 |
TMC6
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS2074738818 |
LOC112529895;SCO1
|
Health Risk |
Likely pathogenic |
— |
| RS2074756863 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2074757362 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2074762701 |
PNKP
|
Health Risk |
Likely pathogenic |
— |
| RS2074764232 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2074766866 |
PNKP
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2074768453 |
PNKP
|
Health Risk |
Likely pathogenic |
— |
| RS2074777487 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2074784617 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2074787192 |
PNKP
|
Health Risk |
Likely pathogenic |
— |
| RS2074797352 |
CNOT3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2074810148 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2074810318 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2074810403 |
CASR
|
Health Risk |
Likely pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2074814252 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2074815332 |
PLS3
|
Health Risk |
Likely pathogenic |
— |
| RS207482230 |
TFG
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary motor and sensory neuropathy, Okinawa type |